시장보고서
상품코드
2089756

헬스케어 제3자 물류 시장 : 시장 규모, 점유율, 동향 분석(산업별, 공급망별, 서비스별, 지역별), 부문별 예측(2026-2033년)

Healthcare Third-party Logistics Market Size, Share & Trends Analysis Report By Industry, By Supply Chain, By Service, By Region, And Segment Forecasts, 2026 - 2033

발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 180 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 5,950 금액 안내 화살표 ₩ 8,864,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 6,950 금액 안내 화살표 ₩ 10,354,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 8,950 금액 안내 화살표 ₩ 13,333,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

헬스케어 제3자 물류 시장 : 요약

세계의 헬스케어 제3자 물류 시장 규모는 2025년에 2,798억 달러로 평가되었고 2026년 3,003억 달러에서 2033년까지 5,221억 달러로 확대되어 2026년부터 2033년까지 연평균 복합 성장률(CAGR)은 8.2%를 나타낼 것으로 예측됩니다.

2025년, 북미의 헬스케어 제3자 물류 시장은 전 세계 시장의 39.4%라는 최대 점유율을 차지했습니다. 헬스케어 제3자 물류 서비스에 대한 수요는 의료 제품에 대한 수요 증가, 기술 발전, 엄격한 규제 준수 등의 요인에 힘입어 증가하고 있습니다.

의료 기업들이 전 세계로 사업을 확장함에 따라, 자원을 효율적으로 관리하고 간접비를 최소화하기 위해 3PL 공급업체에 대한 의존도가 높아지고 있습니다. 또한, DHL 그룹과 Vizient Inc. 간의 계약과 같은 협력 파트너십을 통해 업계가 직면한 과제를 해결하는 동시에 서비스 제공을 한층 더 강화하고 있습니다. 의료 분야의 제조업체, 유통업체 및 서비스 제공업체는 업무 효율을 높이고 비용을 최소화하기 위해 전문 물류 파트너에 의존하고 있습니다.

물류를 3PL 제공업체에 위탁함으로써, 기업은 첨단 공급망 기술을 활용하여 유통 네트워크를 최적화하는 동시에, 온도 관리가 필요한 의약품, 의료기기, 바이오의약품 취급에 관한 전문 지식을 활용할 수 있게 됩니다. 이를 통해 사내 인프라에 대한 막대한 투자 필요성이 줄어들고, 인건비가 절감되며, 재고 관리의 정확도가 향상됩니다. 또한, 3PL 파트너는 전략적인 경로 계획 및 운송업체와의 제휴를 통해 출하 물량의 통합, 라스트 마일 배송의 효율화, 운송 비용 절감을 실현할 수 있습니다. 엄격한 규제 요건을 준수해야 하는 시장에서 3PL 제공업체는 적절한 서류 작성, 라벨 부착, 보관을 철저히 수행함으로써 비용이 많이 드는 실수나 지연을 줄이는 데에도 기여합니다. 업무 최적화와 비용 절감이 맞물리면서 병원, 진료소, 약국, 의료기기 제조업체에서 3PL(제3자 물류) 서비스 도입이 더욱 확대되고 있습니다.

또한, 의료 물류 분야의 지속적인 디지털 전환은 운영 기준을 재정의하고 있으며, 각 의료 서비스 제공업체들은 점점 더 복잡해지고 규제가 강화되는 밸류체인에 대응하기 위해 첨단 도구를 꾸준히 도입하고 있습니다. 지난 3년 동안 이 분야는 기본적인 추적 시스템에서 위험이 발생하기 전에 예측할 수 있는 완벽하게 연동된 데이터 기반 플랫폼으로 전환되었습니다. 예를 들어, UPS Healthcare는 AI를 활용한 모니터링 기능을 통해 콜드체인 네트워크를 확장하고, 온도에 민감한 생물학적 제제나 고가의 백신에 대한 예측 경보 시스템을 구현했습니다. 이듬해, DHL 공급망은 전 세계 의료시설에 IoT 기반 센서 기술을 도입했습니다. 이를 통해, 미세한 환경 변화만으로도 효능에 영향을 미칠 가능성이 있는 세포 치료제나 유전자 치료제 등의 제품에 대해, 전 과정에 걸친 가시화가 가능해졌습니다. 2025년까지 이러한 기능들은 경로와 보관 조건을 모니터링하고 동적으로 조정하는 종합적인 실시간 컨트롤 타워로 발전하여, 공급업체에 기존 물류 모델에 비해 상당한 서비스상의 우위를 가져다줄 것입니다.

자주 묻는 질문

  • 헬스케어 제3자 물류 시장 규모는 어떻게 예측되나요?
  • 2025년 북미의 헬스케어 제3자 물류 시장 점유율은 얼마인가요?
  • 헬스케어 제3자 물류 서비스에 대한 수요는 어떤 요인에 의해 증가하고 있나요?
  • 의료 기업들이 3PL 공급업체에 의존하는 이유는 무엇인가요?
  • 3PL 제공업체를 활용하는 기업의 이점은 무엇인가요?
  • 의료 물류 분야의 디지털 전환은 어떤 변화를 가져오고 있나요?

목차

제1장 분석 방법 및 범위

제2장 주요 요약

제3장 헬스케어 제3자 물류 시장 : 변동 요인, 동향 및 범위

제4장 헬스케어 제3자 물류 시장 : 산업별 추정 및 동향 분석

제5장 헬스케어 제3자 물류 시장 : 서비스별 추정 및 동향 분석

제6장 헬스케어 제3자 물류 시장 : 공급망별 추정 및 동향 분석

제7장 헬스케어 제3자 물류 시장 : 지역별 추정 및 동향 분석

제8장 경쟁 구도

KTH

Healthcare Third-Party Logistics Market Summary

The global healthcare third-party logistics market size was valued at USD 279.8 billion in 2025 and is projected to grow from USD 300.3 billion in 2026 to USD 522.1 billion by 2033, at a CAGR of 8.2% from 2026 to 2033. North America healthcare third-party logistics market held the largest share of 39.4% of the global market in 2025. The demand for healthcare third-party logistics (3PL) services is driven by factors such as the growing need for healthcare products, technological advancements, and stringent regulatory compliance.

As healthcare companies expand globally, they increasingly depend on 3PL providers to manage resources efficiently and minimize overhead costs. In addition, collaborative partnerships, such as DHL Group's agreement with Vizient Inc., further enhance service offerings while addressing industry challenges. Healthcare manufacturers, distributors, and providers rely on specialized logistics partners to streamline operations and minimize expenses.

Outsourcing logistics to 3PL providers enables companies to leverage advanced supply chain technologies, optimize distribution networks, and specialize expertise in handling temperature-sensitive pharmaceuticals, medical devices, and biologics. This reduces the need for heavy in-house infrastructure investments, lowers labor costs, and improves inventory management accuracy. Moreover, 3PL partners can consolidate shipments, improve last-mile delivery efficiency, and reduce transportation costs through strategic route planning and carrier partnerships. In a market where compliance with stringent regulatory requirements is essential, 3PL providers also help mitigate costly errors and delays by ensuring proper documentation, labeling, and storage. The combined impact of operational optimization and cost savings drives greater adoption of third-party logistics services across hospitals, clinics, pharmacies, and healthcare manufacturers.

Moreover, ongoing digital transformation in healthcare logistics has been redefining operational standards, with providers steadily integrating advanced tools to handle increasingly complex and regulated supply chains. Over the past three years, the sector has moved from basic tracking systems to fully connected, data-driven platforms capable of predicting risks before they occur. For instance, the UPS Healthcare expanded its cold chain network with AI-enabled monitoring, enabling predictive alerts for temperature-sensitive biologics and high-value vaccines. The following year, DHL Supply Chain introduced IoT-based sensor technology across its global healthcare facilities. This allows end-to-end visibility for products such as cell and gene therapies, where even minor environmental deviations can impact efficacy. By 2025, these capabilities will have matured into comprehensive, real-time control towers that monitor and dynamically adjust routes and storage conditions, giving providers a significant service advantage over traditional logistics models.

Global Healthcare Third-party Logistics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare third-party logistics market report based on industry, service, supply chain, and region:

  • Industry Outlook (Revenue, USD Billion, 2021 - 2033)
  • Biopharmaceutical
    • Vaccines
    • Biosimilars
    • Plasma Derived Products
    • Others
  • Pharmaceutical
  • Medical Device
    • Class I
    • Class II
    • Class III
  • Service Outlook (Revenue, USD Billion, 2021 - 2033)
  • Transportation
    • Air Freight
    • Sea Freight
    • Overland
  • Warehousing and Storage
  • Other
  • Supply Chain Outlook (Revenue, USD Billion, 2021 - 2033)
  • Cold Chain Logistics
  • Non-cold Chain Logistics
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Industry
    • 1.2.2. Service
    • 1.2.3. Supply Chain
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Bottom-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Healthcare Third-Party Logistics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Enhanced efficiency and cost reduction
      • 3.2.1.2. Strengthened competitive advantage
      • 3.2.1.3. Technological advancements in logistics
      • 3.2.1.4. Growing applications of reverse logistics in biopharmaceutical industry
      • 3.2.1.5. Rising demand for cold chain logistics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Increased risk of data and regulatory breaches
      • 3.2.2.2. Rising operational costs and labor shortages
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Value Chain Analysis
    • 3.6.1. Supply Trends
    • 3.6.2. Demand Trends
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Force Analysis
    • 3.7.2. PESTEL by SWOT Analysis

Chapter 4. Healthcare Third-Party Logistics Market: Industry Estimates & Trend Analysis

  • 4.1. Healthcare Third-Party Logistics Market, By Industry: Segment Dashboard
  • 4.2. Healthcare Third-Party Logistics Market, By Industry: Movement Analysis
  • 4.3. Healthcare Third-Party Logistics Market Estimates & Forecasts, By Industry, 2021 - 2033 (USD Billion)
  • 4.4. Biopharmaceutical
    • 4.4.1. Biopharmaceutical Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.2. Vaccines
      • 4.4.2.1. Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.3. Biosimilars
      • 4.4.3.1. Biosimilars Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.4. Plasma Derived Products
      • 4.4.4.1. Plasma Derived Products Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.5. Pharmaceutical
    • 4.5.1. Pharmaceutical Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.6. Medical Device
    • 4.6.1. Medical Device Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.6.2. Class I
      • 4.6.2.1. Class I Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.6.3. Class II
      • 4.6.3.1. Class II Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.6.4. Class III
      • 4.6.4.1. Class III Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Healthcare Third-Party Logistics Market: Service Estimates & Trend Analysis

  • 5.1. Healthcare Third-Party Logistics Market, By Service: Segment Dashboard
  • 5.2. Healthcare Third-Party Logistics Market, By Service: Movement Analysis
  • 5.3. Healthcare Third-Party Logistics Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Billion)
  • 5.4. Transportation
    • 5.4.1. Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 5.4.2. Air Freight
      • 5.4.2.1. Air Freight Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 5.4.3. Sea Freight
      • 5.4.3.1. Sea Freight Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 5.4.4. Overland
      • 5.4.4.1. Overland Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.5. Warehousing and Storage
    • 5.5.1. Warehousing and Storage Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.6. Other
    • 5.6.1. Other Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Healthcare Third-Party Logistics Market: Supply Chain Estimates & Trend Analysis

  • 6.1. Healthcare Third-Party Logistics Market, By Supply Chain: Segment Dashboard
  • 6.2. Healthcare Third-Party Logistics Market, By Supply Chain: Movement Analysis
  • 6.3. Healthcare Third-Party Logistics Market Estimates & Forecasts, By Supply Chain, 2021 - 2033 (USD Billion)
  • 6.4. Cold Chain Logistics
    • 6.4.1. Cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 6.5. Non-Cold Chain Logistics
    • 6.5.1. Non-Cold Chain Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Healthcare Third-Party Logistics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2025 & 2033
  • 7.3. North America
    • 7.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.3.2. U.S
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.4. Europe
    • 7.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.6. Latin America
    • 7.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 7.7. MEA
    • 7.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.7.3. UAE
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.7.4. Saudi Arabia
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.7.6. Qatar
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.7.7. Oman
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Key Participant Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Market Assessment Analysis, 2025 (Heat Map Analysis)
  • 8.3. Company Profiles
    • 8.3.1. Cardinal Health
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. DHL Group
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Agility
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. SF Express
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Kinesis Medical B.V.
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. United Parcel Service of America, Inc.
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Barrett Distribution
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. AmerisourceBergen Corporation
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. DB Schenker
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. FedEx
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. KUEHNE + NAGEL
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Service Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Kerry Logistics Network Ltd.
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Service Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. Freight Logistics Solutions
      • 8.3.13.1. Company Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Service Benchmarking
      • 8.3.13.4. Strategic Initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기